Methods for treating bone cancer pain by administering a nerve growth factor antagonist

Details for Australian Patent Application No. 2005243247 (hide)

Owner Rinat Neuroscience Corp. Regents of The University of Minnesota

Inventors Mantyh, Patrick William; Shelton, David L.

Agent Shelston IP

Pub. Number AU-B-2005243247

PCT Pub. Number WO2005/111077

Priority 60/560,781 07.04.04 US; 60/620,654 19.10.04 US

Filing date 7 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 1 March 2012

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/111077 Priority application(s): WO2005/111077

1 March 2012 Application Accepted

  Published as AU-B-2005243247

28 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243250-Immunostimulatory nucleic acids for inducing IL-10 responses

2005243242-Method of making a corrosion-resistant non-stick coating